Teebaconin Uses, Dosages, and Side Effects Information

Introduction

Teebaconin , also known as isoniazid, is an essential antibiotic medication used to treat and prevent tuberculosis (TB) infections. As a key component of TB treatment regimens, Teebaconin has played a vital role in global efforts to control the spread of this infectious disease.

Uses of Teebaconin

Treating Active Tuberculosis (TB)

Teebaconin is a cornerstone of active tuberculosis treatment, typically used in combination with other medications such as rifampin, ethambutol, and pyrazinamide. This multi-drug approach helps to effectively eliminate TB infections and reduce the risk of drug resistance [1].

Preventing TB in High-Risk Populations

Teebaconin is also used for tuberculosis prophylaxis in individuals with latent TB infection who are at high risk of developing active disease. Preventive treatment with isoniazid significantly reduces the likelihood of progression to active TB [2].

Administration and Dosage

Oral Forms

Teebaconin is available in various oral formulations, including standalone tablets and fixed-dose combination products with other TB medications like Rifapentine. The drug is typically administered orally once daily [3].

Standard Dosages for Adults and Children

The recommended dosage of Teebaconin varies based on factors such as age, weight, and the specific condition being treated. Generally, adults receive 300 mg daily for latent TB infection treatment and 5 mg/kg daily (up to 300 mg) for active TB therapy. Dosages for children are weight-based and typically range from 10-15 mg/kg daily [3].

Side Effects of Teebaconin

Common Side Effects

Common side effects of Teebaconin include nausea, vomiting, loss of appetite, and mild skin rash. These symptoms are usually mild and do not require discontinuation of treatment [3].

Serious Side Effects

Rare but serious side effects of isoniazid include hepatotoxicity, peripheral neuropathy, and hypersensitivity reactions. Regular monitoring of liver function and prompt recognition of adverse events are essential for safe use of the medication [4].

Interactions with Other Drugs

Potential Drug Interactions

Teebaconin may interact with several common medications, including acetaminophen, carbamazepine, and phenytoin. These interactions can affect the metabolism or efficacy of isoniazid or the interacting drug [3].

Contraindications

Teebaconin is contraindicated in patients with severe liver disease, acute liver injury, or a history of isoniazid-induced hepatitis. Caution should be exercised when using the drug in individuals with pre-existing liver conditions or alcohol dependence [3].

Pictures and Identifiers of Teebaconin

Visual Identification of the Drug

Teebaconin tablets are typically white to off-white in color and may be round or oblong in shape, depending on the manufacturer. The tablets often have identifying markings such as “INH” or the strength of the dose [5].

Chemical Structure

Teebaconin (isoniazid) has the molecular formula C6H7N3O and is chemically known as pyridine-4-carbohydrazide. Its CID 3767 and systematic name is 4-pyridinecarboxylic acid hydrazide Isoniazid” target=”_blank”>[6].

Drug Development and Pipeline

New Formulations and Combinations

Pharmaceutical companies like Lupin are developing new fixed-dose combination products that include Teebaconin along with other TB medications, aiming to simplify treatment regimens and improve patient adherence [7].

Regulatory and Approval Information

FDA Approval Status

Teebaconin (isoniazid) is approved by the U.S. Food and Drug Administration ( FDA) for the treatment and prevention of tuberculosis. It is considered an essential medicine and is widely available as a generic drug [8].

Drug Master File (DMF) Details

Manufacturers of Teebaconin active pharmaceutical ingredient ( API) must submit a Drug Master File ( DMF) to the FDA, providing detailed information about the manufacturing process, quality control, and stability of the drug substance [9].

Manufacturing and Quality Control

Active Pharmaceutical Ingredient (API) Manufacturing

The manufacturing process for Teebaconin API involves the synthesis of isoniazid from 4-cyanopyridine and hydrazine hydrate. Quality control measures, such as impurity testing and polymorphism control, ensure the production of a consistent and high-quality API [10].

Latent and Active TB Treatment Protocols

Treatment of Latent TB Infection

Teebaconin is a key component of latent tuberculosis treatment protocols. The most common regimen for latent TB infection is 9 months of daily isoniazid, which has been shown to reduce the risk of progression to active disease by up to 90% [11].

Combination Therapy for Active TB

For active TB therapy, Teebaconin is used in combination with other antibiotics, typically rifampin, ethambutol, and pyrazinamide. The standard regimen consists of a 2-month intensive phase with all four drugs, followed by a 4-month continuation phase with isoniazid and rifampin [12].

Tuberculosis Prophylaxis

Preventive Measures for High-Risk Groups

Teebaconin is used for tuberculosis prophylaxis in high-risk populations, such as individuals with HIV, close contacts of active TB cases, and those with radiographic evidence of prior untreated TB. Preventive treatment significantly reduces the risk of developing active disease [13].

Chemical Properties and Composition

Molecular Formula: C6H7N3O

Teebaconin (isoniazid) has the molecular formula C6H7N3O and a molecular weight of 137.14 g/mol. It is a white, crystalline powder that is soluble in water and slightly soluble in ethanol Isoniazid#section=Chemical-and-Physical-Properties” target=”_blank”>[14].

Research and Scientific Studies

Latest Research Findings

Recent studies have focused on optimizing Teebaconin treatment protocols, exploring new drug combinations, and investigating the potential use of isoniazid for the prevention of TB in high-risk populations. Ongoing research aims to improve the effectiveness and safety of TB treatment and prevention strategies [15].

Historical Context and Discovery

Discovery of Isoniazid

Teebaconin (isoniazid) was first synthesized in 1912 but its antitubercular properties were not discovered until 1951. The introduction of isoniazid revolutionized TB treatment, offering a highly effective and well-tolerated option for both active and latent TB infections [16].

Public Health Impact

Role in TB Control Programs

Teebaconin has played a crucial role in global TB control efforts, contributing to significant reductions in TB incidence and mortality. Its effectiveness, affordability, and safety have made it an essential component of national and international TB prevention and treatment programs [17].

Alternative Names and Abbreviations

Common Trade Names

Teebaconin is marketed under various trade names, including Tisin and Tyvid. These brand names may vary by country and manufacturer [18].

Abbreviations

The most common abbreviation for Teebaconin (isoniazid) is INH. This abbreviation is widely used in medical literature and clinical practice [3].

Interactive and Educational Resources